Author

Chiara Tavanti

Sapienza University of Rome

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Approach:statistical model· 1

Frequent Co-Authors

Alessandro CorsiiD· 3 shared Biagio PalmisanoiD· 3 shared Giorgia FarinacciiD· 3 shared Mara RiminucciiD· 3 shared Marta SerafiniiD· 2 shared Natasha M. Appelman‐DijkstraiD· 2 shared Samantha DonsanteiD· 2 shared Alessia CiarrocchiiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPathology

Alessandro CorsiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Exploring the mechanism and pattern of bone formation during RANKL inhibition in a mouse model of fibrous dysplasia

Giorgia Farinacci, Ilenia Coletta, Biagio Palmisano, Emanuela Spica, Chiara Tavanti, Samuele Di Cristofano, Samantha Donsante, Marta Serafini, Tiziana Borsello, Mary Anna Venneri, Alessandro Corsi, Debora Salerno, Benedetta Donati, Alessia Ciarrocchi, Domenico Raimondo, Mara Riminucci

This study investigates how RANKL inhibition affects bone formation in a mouse model of fibrous dysplasia, finding that bone formation is restricted to specific surfaces rather than occurring diffusely.

Communications Biology · Apr 22, 2026Peer-reviewedPathology

Effects of anti-RANKL, Zoledronate or combination therapy in a mouse model of Fibrous Dysplasia: a preclinical study

Biagio Palmisano, Chiara Tavanti, Giorgia Farinacci, Alessandro Corsi, Marta Serafini, Natasha M. Appelman‐Dijkstra, Mara Riminucci

This study evaluates the combination of zoledronate and anti-RANKL therapy in a mouse model of fibrous dysplasia, showing delayed disease rebound and improved bone density.

Journal of Bone and Mineral Research · Feb 22, 2026Peer-reviewedPathology

Bone pain in Fibrous dysplasia does not rely on aberrant sensory nerve sprouting or neuroma formation

Biagio Palmisano, Chiara Tavanti, Giorgia Farinacci, Giorgio Gosti, Marco Leonetti, Samantha Donsante, Giuseppe Giannicola, Natasha M. Appelman‐Dijkstra, Alessandro Corsi, Ernesto Ippolito, Mara Riminucci

This study shows that bone pain in Fibrous dysplasia is intrinsic and not caused by abnormal sensory nerve sprouting or neuroma formation.

Journal of Bone and Mineral Research · May 3, 2025Peer-reviewedPathology